Navigation Links
Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference In New York
Date:8/31/2011

NASHVILLE, Tenn., Aug. 31, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the UBS Global Life Sciences Conference at the Grand Hyatt New York on Monday, September 19, 2011, at 8:00 a.m. Eastern Time.

The presentation will be simultaneously webcast and can be accessed through the Investor Relations section of Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.  Shortly following the live webcast a replay will also be available on the Company's website.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® for the treatment of acetaminophen poisoning, Caldolor®, the first injectable treatment for pain and fever approved in the United States, and Kristalose®, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information, please visit the Company website at www.cumberlandpharma.com.


'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
5. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
6. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2020)... Mass. (PRWEB) , ... September 02, 2020 , ... ... handheld 1064nm Raman technology, will moderate a roundtable discussion among industry professionals about ... roundtable will be hosted by American Pharmaceutical Review and will take ...
(Date:9/1/2020)... ... September 01, 2020 , ... Agilent, ... the Agilent Science and Technology Virtual Symposium 2020 (ASTVS 2020) on ... open a suite of Live webinars and Networking sessions, with a vast array ...
(Date:9/1/2020)... , ... September 01, 2020 , ... While coronavirus cases ... rate as businesses, schools and community organizations remain closed. Because about 80% of blood ... the help of both blood donors and blood drive hosts to ensure blood products ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... 2020 , ... Colorado State University Global (CSU Global) – ... education – is proud to announce its new master’s degree in Military ... in the nation, the 60-credit hour program is designed to provide students with ...
(Date:8/31/2020)... MAUI, Hawaii (PRWEB) , ... August 31, 2020 , ... A Cure for Covid-19 “PTS” ... most people on the planet are in a state of panic, experiencing deep anxiety, immense ... , Right now, a solution is timely when most people on the planet are experiencing ...
(Date:8/31/2020)... Conn. (PRWEB) , ... August 31, 2020 , ... ... device intended to improve outcomes for patients with advanced heart failure, today announced ... (SBIR) grant in the amount of $555,358 from the National Heart, Lung, and ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... designed to help treat patients with respiratory conditions, including COVID-19, while reducing the ... and oxygen, but it captures exhaled gas and scrubs it free of carbon ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... Integrated ... Miami is the first Florida school to deploy its breakthrough Mobile Biodefense Indoor Air ... airborne COVID-19. True North Classical Academy plans to fully reopen equipped with the filtration ...
Breaking Medicine News(10 mins):